High rate of virological failure in maintenance antiretroviral therapy with didanosine and tenofovir.

León, Agathe; Mallolas, Josep; Martinez, Esteban; De Lazzari, Elisa; Pumarola, Tomás; Larrousse, María; Milincovic, Ana; Lonca, Montserrat; Blanco, Jose Luis; Laguno, Montserrat; Biglia, Alejandra; Gatell, Josep María

León, Agathe; Mallolas, Josep; Martinez, Esteban; De Lazzari, Elisa; Pumarola, Tomás; Larrousse, María; Milincovic, Ana; Lonca, Montserrat; Blanco, Jose Luis; Laguno, Montserrat; Biglia, Alejandra; Gatell, Josep María.

Affiliation

León A; Infectious Diseases Unit, Hospital Clinic, University of Barcelona, Spain.

AIDS ; 19(15): 1695-7, 2005 Oct 14.

Article in En | MEDLINE | ID: mdl-16184042

Subject(s)

Adenine/analogs & derivatives; Anti-HIV Agents/therapeutic use; Didanosine/therapeutic use; HIV Infections/drug therapy; HIV-1/drug effects; Organophosphonates/therapeutic use; Adenine/therapeutic use; Antiretroviral Therapy, Highly Active; Drug Resistance, Multiple, Viral; HIV Infections/virology; HIV-1/genetics; Humans; Mutation; Tenofovir; Treatment Failure

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Adenine / HIV Infections / HIV-1 / Didanosine / Anti-HIV Agents / Organophosphonates Limits: Humans Language: En Journal: AIDS Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2005 Type: Article Affiliation country: Spain

Search on Google

XML

PubMed Links